

Cover Story
Free
By Matthew Bin Han Ong
The White House moonshot to accelerate progress in cancer research directs FDA to consolidate its oncology portfolio.
In Brief


Funding Opportunities
Drugs & Targets


Trending Stories
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center











